See also this year's filing and all EDGAR filings for this company.
PDF Report 0001638833_2020_Surgery_Partners_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.4718388423166417, 'aggregate_val': 1657000000, 'exp_sum': 3137300000, 'exp_to_value': {'LaborExpense': 550300000, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 97100000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 1480300000, 'DepreciationDepletionAndAmortization': 94800000, 'SellingAndMarketingExpense': 0, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': 914800000}} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.46686567164179105, 'aggregate_val': 1607400000, 'exp_sum': 3015000000, 'exp_to_value': {'LaborExpense': 550000000, 'CostOfGoodsAndServicesSold': 1407600000, 'GeneralAndAdministrativeExpense': 88600000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 617200000, 'DepreciationDepletionAndAmortization': 76500000, 'SellingAndMarketingExpense': 0, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': 275100000}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001638833, Surgery Partners Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 3,449,700,000 |
| 1 | AssetsNonCurrent | 328,500,000 |
| 2 | AssetsCurrent | 525,500,000 |
| 3 | PropertyPlantAndEquipment | 0 |
| 4 | remainder_Assets | 715,200,000 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 398,100,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 550,000,000 |
| 9 | CostOfGoodsAndServicesSold | 1,407,600,000 |
| 10 | GeneralAndAdministrativeExpense | 88,600,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 617,200,000 |
| 13 | DepreciationDepletionAndAmortization | 76,500,000 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | -1,132,500,000 |
| 17 | remainder_Revenues | 1,831,400,000 |
| 18 | remainder_NetIncome | -178,900,000 |
| 19 | remainder_ComprehensiveNetIncome | -148,200,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 5,018,900,000 |
| 1 | Liabilities | 398,100,000 |
| 2 | Expenses | 1,607,400,000 |
| 3 | Revenues | 1,831,400,000 |
| 4 | StockholdersEquity | 4,620,800,000 |
| 5 | NetIncome | 45,100,000 |
| 6 | ComprehensiveNetIncome | -103,100,000 |
| 7 | BaseVar | 4,591,450,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.44 |
| 9 | EconomicCapitalRatio | 2.69 |